Status:
UNKNOWN
Tranexamic Acid vs Fractional CO2 Laser in Post-acne Hyperpigmentation
Lead Sponsor:
Cairo University
Conditions:
Post Inflammatory Hyperpigmentation
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
comparing between the effect of intradermal injection of TXA and low power low density fractional CO2 lasers on post acne hyperpigmentation
Detailed Description
Randomized controlled split-face study. One side of the face will be assigned to TXA intradermal microinjection using Kapron 500mg/5ml ampoules (Amoun Pharmaceutical Company), the dose of 1 ml syringe...
Eligibility Criteria
Inclusion
- Egyptians of both sexes.
- Age \> 18.
- Patients who can avoid sun exposure one week after sessions.
- Patients who stopped taking systemic isotretinoin for more than six months.
Exclusion
- Pregnancy and lactation.
- Concomitant use of anticoagulants.
- Bleeding disorders.
- Personal or family history of DVT or thromboembolic events.
- Scarring and keloid tendency.
- Active skin infection, active HSV.
- History of photosensitivity or photosensitizing medication.
- Occupational sun exposure.
Key Trial Info
Start Date :
December 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2019
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT03765021
Start Date
December 1 2018
End Date
July 1 2019
Last Update
December 5 2018
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.